Drugs / HEC74647
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04232514 | Jul → Aug 2020 | chronic hepatitis C virus infection | Sunshine Lake Pharma Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HEC74647 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04232514 ↗ |
| Route | Oral | “Administered HEC74647 200 mg orally once daily in fed state” NCT04232514 ↗ |